“…Curtis, 1962) are usually sufficient to abolish strychnine-sensitive inhibition in the spinal cord (Bradley, Easton & Eccles, 1953) and medulla (Kidokora, Kubota, Shuto & Sumino, 1968; Morimoto, Takata & Kawamura, 1968). Since large doses of strychnine can be less specific and interact with GABA and glycine in the spinal cord (Davidoff, Aprison & Werman, 1969) and not infrequently in the cuneate nucleus (Kelly & Renaud, 1973b), it must be of significance that synaptic inhibition was quite unaffected by iontophoretic applications of strychnine in excess of 100 nA and repeated intrav-enous injections, whose cumulative dose often exceeded 2 mg/kg. The GABA/strychnine interaction which was reported in the preceding paper (Kelly & Renaud, 1973b) must therefore only occur rarely or at extrajunctional sites where the GABA receptors are not involved in synaptic transmission.…”